SPL
Live / Registered — Registered (as of 09 Apr 2024)
What this means for you
Registered since 09 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97898955
- Registration number
- 7355282
- Mark type
- Stylized text
- Filed
- 20 Apr 2023
- Published for opposition
- 23 Jan 2024
- Registered
- 09 Apr 2024
- Attorney of record
- Gordon M. Wright
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations containing active pharmaceutical ingredients, namely, pharmaceutical grade Heparin Sodium, pharmaceutical grade Pancreatin, and pharmaceutical grade Pancrealipase, for use in humans for the prevention and treatment of thrombotic events and to treat pancreatic insufficiency and related diseases; Pharmaceutical products and preparations, namely, anticoagulants; pharmaceutical products and preparations for the testing, sampling and identification of viruses, namely, medical diagnostic reagents and assays for testing of body fluids; Chemical preparations for sanitary use; Chemical preparations for treating mildew; Diagnostic preparations for medical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating thyroid conditions; Pharmaceutical preparations for wounds; Diagnostic preparations for use with medical devices; Pharmaceutical preparations for treating thrombotic events and pancreatic insufficiency for use with medical devices for drug delivery; Pharmaceutical preparations for ophthalmological use, namely, for treating eye diseases and disorders; none of the foregoing for use with animals
- Class 040 — Treatment of materials: Manufacturing services for others in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds
- Class 042 — Scientific and technological services: Pharmaceutical contract development in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds
Owner
- Hepalink USA Inc., Langhorne, PA, US
- Hepalink USA Inc., Langhorne, PA, US
- Hepalink USA Inc., Langhorne, PA, US
Prosecution history
- 09 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jan 2024 — PUBLISHED FOR OPPOSITION
- 03 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Dec 2023 — EXAMINER'S AMENDMENT ENTERED
- 12 Dec 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Dec 2023 — EXAMINERS AMENDMENT E-MAILED
- 12 Dec 2023 — EXAMINERS AMENDMENT -WRITTEN
- 04 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Nov 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Aug 2023 — NON-FINAL ACTION E-MAILED